{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:37:18Z","timestamp":1769441838934,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004901","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000}}],"reference-count":72,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004901.pub2","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T18:24:34Z","timestamp":1271183074000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death"],"prefix":"10.1002","volume":"2018","author":[{"given":"Jodie M","family":"Dodd","sequence":"first","affiliation":[{"name":"The University of Adelaide, Women's and Children's Hospital; School of Paediatrics and Reproductive Health, Discipline of Obstetrics and Gynaecology; 72 King William Road Adelaide South Australia Australia 5006"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline A","family":"Crowther","sequence":"additional","affiliation":[{"name":"The University of Auckland; Liggins Institute; Private Bag 92019 85 Park Road Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajog.2003.09.037","article-title":"Randomized controlled trial of misoprostol for second trimester pregnancy termination associated with fetal malformation","volume":"190","author":"Akoury","year":"2004","journal-title":"American Journal Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/mob.2002.127461","article-title":"A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination","volume":"187","author":"Bebbington","year":"2002","journal-title":"American Journal Obstetrics and Gynecology"},{"issue":"21","key":"10.1002\/14651858.CD004901.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3923\/pjbs.2008.2505.2508","article-title":"Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial","volume":"11","author":"Behrashi","year":"2008","journal-title":"Pakistan Journal of Biological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0004|cit4","first-page":"173","article-title":"Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation","volume":"50","author":"Caliskan","year":"2005","journal-title":"Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004901.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13625180802360865","article-title":"Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial","volume":"14","author":"Caliskan","year":"2009","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00006250-200306000-00044","article-title":"A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death","volume":"101","author":"Chittacharoen","year":"2003","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0007|cit7","first-page":"115","article-title":"Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial","volume":"7","author":"Dickinson","year":"1998","journal-title":"Journal of Maternal-Fetal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mob.2002.121085","article-title":"The optimization of intravaginal misoprostol dosing schedules in second trimester pregnancy termination","volume":"186","author":"Dickinson","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0009|cit9","first-page":"1294","article-title":"A comparison of oral misoprostol with vaginal misoprostol administration in second trimester pregnancy termination for fetal abnormality","volume":"101","author":"Dickinson","year":"2003","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD004901.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijgo.2007.06.042","article-title":"Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second-trimester fetal demise","volume":"100","author":"Elhassan","year":"2008","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijgo.2003.12.006","article-title":"Oral misoprostol vs vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second trimester","volume":"86","author":"Fadalla","year":"2004","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1067\/S0002-9378(03)00659-8","article-title":"A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination","volume":"189","author":"Feldman","year":"2003","journal-title":"American Journal Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0013|cit13","first-page":"429","article-title":"Second trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol: a comparative study","volume":"77","author":"Ghorab","year":"1998","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1479-828X.2001.tb01318.x","article-title":"A randomised trial of oral versus vaginal administration of misoprostol for the purpose of mid-trimester termination of pregnancy","volume":"41","author":"Gilbert","year":"2001","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1471-0528.2003.00044.x-i1","article-title":"Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial","volume":"111","author":"Grimes","year":"2005","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0016|cit16","unstructured":"Herabutya Y O-Prasertsawat P A comparison of intravaginal misoprostol with intracervical prostaglandin E2 gel for the management of dead fetus in utero Thai Journal of Obstetrics and Gynaecology 1997 95 8"},{"issue":"9","key":"10.1002\/14651858.CD004901.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1471-0528.2005.00727.x","article-title":"A randomised trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination","volume":"112","author":"Herabutya","year":"2005","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD004901.pub2-BIB0018|cit18","first-page":"439","article-title":"Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea: a prospective randomized trial","volume":"30","author":"Hidar","year":"2001","journal-title":"Journal de Gynecologie, Obstetrique et Biologie de la Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00404-005-0053-7","article-title":"Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks","volume":"273","author":"Hidar","year":"2005","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9378(96)70270-3","article-title":"A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion","volume":"175","author":"Jain","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0021|cit21","first-page":"571","article-title":"A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination","volume":"93","author":"Jain","year":"1999","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199408043310502","article-title":"A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second trimester pregnancy","volume":"331","author":"Jain","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004901.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14767050802283027","article-title":"Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy","volume":"21","author":"Jansen","year":"2008","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0024|cit24","first-page":"13","article-title":"Comparison of misoprostol and dinoproston administration for the induction of labour in second trimester pregnancies in cases of intrauterine fetal loss","volume":"11","author":"Kara","year":"1999","journal-title":"Italian Journal of Gynaecology & Obstetrics"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0144361031000120923","article-title":"Second-trimester pregnancy termination: comparison of three different methods","volume":"23","author":"Makhlouf","year":"2003","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/004947550103100315","article-title":"The use of misoprostol for mid-trimester therapeutic termination of pregnancy","volume":"31","author":"Munthali","year":"2001","journal-title":"Tropical Doctor"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0027|cit27","first-page":"55","article-title":"A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra-uterine fetal death in Mulago Hospital, Uganda","volume":"1","author":"Nakintu","year":"2001","journal-title":"African Health Sciences"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0028|cit28","first-page":"205","article-title":"Tocographic pattern caused by misoprostol","volume":"106","author":"Neto","year":"1988","journal-title":"Revista Paulista de Medicina"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijgo.2005.02.018","article-title":"Second trimester abortion using intravaginal misoprostol","volume":"89","author":"Niromanesh","year":"2005","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD004901.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/01443610600811383","article-title":"Misoprostol (alone) in second trimester terminations of pregnancy: as effective as Gemeprost?","volume":"26","author":"Nor Azlin","year":"2006","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD004901.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0029-7844(97)00491-2","article-title":"A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion","volume":"90","author":"Nuutila","year":"1997","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0032|cit32","first-page":"179","article-title":"Comparison of vaginal and oral misoprostol, for the induction of labour in women with intra-uterine foetal death","volume":"81","author":"Nyende","year":"2004","journal-title":"East African Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0033|cit33","first-page":"179","article-title":"Vaginal misoprostol vs concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination","volume":"81","author":"Owen","year":"1999","journal-title":"Journal of Maternal-Fetal Medicine"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(99)70081-5","article-title":"Second trimester uterine evacuation: a comparison of intra-amniotic (15-S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol","volume":"181","author":"Perry","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijgo.2004.07.022","article-title":"Intravaginal misoprostol for pregnancy termination","volume":"87","author":"Pongsatha","year":"2004","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD004901.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.AOG.0000128947.31887.94","article-title":"Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction","volume":"104","author":"Ramsey","year":"2004","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ajog.2005.02.082","article-title":"A prospective randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy","volume":"193","author":"Su","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0038|cit38","first-page":"197","article-title":"A randomized comparison of misoprostol and carprost for termination of second trimester pregnancy","volume":"14","author":"Zuo","year":"1998","journal-title":"Chinese Journal of Clinical Pharmacology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD004901.pub2-BIB0039|cit39","first-page":"S5","article-title":"A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial","volume":"89","author":"Ayudhaya","year":"2006","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0040|cit40","first-page":"211","article-title":"Comparative study of intravaginal misoprostol and extra amniotic ethacridine lactate instillation for mid trimester pregnancy termination","volume":"57","author":"Biswas","year":"2007","journal-title":"Journal of Obstetrics and Gynaecology of India"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.humrep.a135965","article-title":"Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens","volume":"10","author":"El-Refaey","year":"1995","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1479-828X.1997.tb02424.x","article-title":"Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion","volume":"37","author":"Eng","year":"1997","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(01)00171-8","article-title":"Outpatient second trimester pregnancy termination","volume":"63","author":"Gonzalez","year":"2001","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD004901.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000088048","article-title":"Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination","volume":"20","author":"Guix","year":"2005","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1447-0756.2001.tb01235.x","article-title":"Second trimester pregnancy termination: A comparison of 600 and 800 micrograms of intravaginal misoprostol","volume":"27","author":"Herabutya","year":"2001","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"11","key":"10.1002\/14651858.CD004901.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1701-2163(16)30499-6","article-title":"A randomized trial comparing oral misoprostol with intra-amniotic prostaglandin f2alpha for second trimester terminations","volume":"27","author":"Marquette","year":"2005","journal-title":"Journal of Obstetrics & Gynaecology Canada: JOGC"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijgo.2005.11.010","article-title":"Vaginal vs. oral misoprostol for mid-trimester abortion","volume":"92","author":"Nigam","year":"2006","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0048|cit48","first-page":"81-2, 84","article-title":"Medical abortion in late second trimester--a comparative study with misoprostol through vaginal versus oral followed by vaginal route","volume":"104","author":"Saha","year":"2006","journal-title":"Journal of the Indian Medical Association"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0301-2115(95)02548-0","article-title":"Second trimester pregnancy termination including fetal death: comparison of five different methods","volume":"69","author":"Yapar","year":"1996","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"167:2","key":"10.1002\/14651858.CD004901.pub2-BIB0050|cit50","first-page":"26","article-title":"PGE1 analogue for the induction of midtrimester abortion in cases of intrauterine fetal death","volume":"76","author":"Abdel Fattah","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica Supplement"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0051|cit51","unstructured":"Agrawal S Rath SK Misoprostol for second trimester medical abortion - a comparison of three routes of administration [abstract] 49th All India Congress of Obstetrics and Gynaecology; 2006 Jan 6-9; Cochin, Kerala State, India 2006 47"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004901.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.ajog.2004.10.137","article-title":"Comparative efficacy of high dose vaginal misoprostol for mid-trimester labor induction [abstract]","volume":"191","author":"Nuthalapaty","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004901.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ajog.2003.10.036","article-title":"The efficacy of oral versus vaginal misoprostol for second-trimester termination of pregnancy: a double-blind, randomized, placebo controlled trial [abstract]","volume":"189","author":"Roy","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"167:2","key":"10.1002\/14651858.CD004901.pub2-BIB0054|cit54","first-page":"32","article-title":"Misoprostol versus laminaria for cervical ripening in intrauterine fetal death","volume":"76","author":"Surita","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica Supplement"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001338.pub2","article-title":"Oral misoprostol for induction of labour","author":"Alfirevic","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001233","article-title":"Mechanical methods for induction of labour","author":"Boulvain","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0057|cit57","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic reviews in health care: meta-analysis in context","author":"Deeks","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003098","article-title":"Oral prostaglandin E2 for induction of labour","author":"French","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000494.pub3","article-title":"Prostaglandins for preventing postpartum haemorrhage","author":"Gulmezoglu","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"1","key":"10.1002\/14651858.CD004901.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000941","article-title":"Vaginal misoprostol for cervical ripening and induction of labour","author":"Hofmeyr","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003092","article-title":"Extra-amniotic prostaglandin for induction of labour","author":"Hutton","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003246","article-title":"Intravenous oxytocin alone for cervical ripening and induction of labour","author":"Kelly","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003101","article-title":"Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term","author":"Kelly","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004901.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002864","article-title":"Intravenous prostaglandin for induction of labour","author":"Luckas","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0067|cit67","article-title":"Labor induction including pregnancy termination for fetal anomaly","volume-title":"High risk pregnancy management options","author":"Mackenzie","year":"1999"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0068|cit68","first-page":"325","article-title":"Use of misoprostol for induction of labour in stillbirths","volume":"105","author":"Mariani-Neto","year":"1987","journal-title":"Revista Paulista de Medicina"},{"issue":"2","key":"10.1002\/14651858.CD004901.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005216","article-title":"Medical methods for mid-trimester termination of pregnancy","author":"Medema","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004901.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002253.pub3","article-title":"Medical treatment for early fetal death (less than 24 weeks)","author":"Neilson","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0071|cit71","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD004901.pub2-BIB0072|cit72","article-title":"Fetal Death","volume-title":"High risk pregnancy management options","author":"Weiner","year":"1999"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004901.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T09:20:09Z","timestamp":1676020809000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004901.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004901.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}